Hancock Jaffe Laboratories Inc Ret. on equity
What is the Ret. on equity of Hancock Jaffe Laboratories Inc?
The Ret. on equity of Hancock Jaffe Laboratories Inc is -55.76%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Hancock Jaffe Laboratories Inc
What does Hancock Jaffe Laboratories Inc do?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Companies with ret. on equity similar to Hancock Jaffe Laboratories Inc
- Lefteris Acquisition has Ret. on equity of -55.90%
- Luckin Coffee has Ret. on equity of -55.86%
- E.Merge Technology Acquisition has Ret. on equity of -55.84%
- Pan Global Resources has Ret. on equity of -55.78%
- ANGLE Plc has Ret. on equity of -55.77%
- Parrot SA has Ret. on equity of -55.77%
- Hancock Jaffe Laboratories Inc has Ret. on equity of -55.76%
- Baofeng Modern International has Ret. on equity of -55.76%
- The Agency Australia has Ret. on equity of -55.74%
- Lands` End has Ret. on equity of -55.66%
- Laurion Mineral Exploration has Ret. on equity of -55.66%
- Integra Resources has Ret. on equity of -55.64%
- Integra Resources has Ret. on equity of -55.64%